logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
Showing 1 - 5 of 5 Items
Showing 1 - 5 of 5 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Tuberculosis diagnosis and preventive monotherapy among children and adolescents exposed to rifampicin-resistant tuberculosis in the household

Apolisi I, Cox HS, Tyeku N, Daniels J, Mathee S,  et al.
2023-02-21 • Open Forum Infectious Diseases
2023-02-21 • Open Forum Infectious Diseases
BACKGROUND
Children and adolescents with household exposure to multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) are at high risk of developing TB disease. Tuberculosis pre...
Journal Article
|
Letter

Pediatric delamanid treatment for children with rifampicin-resistant TB

Tyeku N, Apolisi I, Daniels J, Beko B, Memani B,  et al.
2022-10-01 • International Journal of Tuberculosis and Lung Disease
2022-10-01 • International Journal of Tuberculosis and Lung Disease
Journal Article
|
Commentary

Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa

Apolisi I, Mema N, Tyeku N, Beko B, Memani B,  et al.
2022-03-01 • Lancet Respiratory Medicine
2022-03-01 • Lancet Respiratory Medicine
Journal Article
|
Commentary

Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic

Mohr-Holland E, Douglas-Jones B, Apolisi I, Ngambu N, Mathee S,  et al.
2021-03-01 • Lancet Child and Adolescent Health
2021-03-01 • Lancet Child and Adolescent Health
Journal Article
|
Commentary

Barriers and solutions to finding rifampicin-resistant tuberculosis cases in older children and adolescents

Mohr-Holland E, Apolisi I, Reuter A, De Azevedo V, Hill JE,  et al.
2019-12-21 • Public Health Action
2019-12-21 • Public Health Action
Little is known about the barriers to post-exposure management of rifampicin-resistant tuberculosis (RR-TB) in older children and adolescents. We report on implementation lessons from a ...